Mr. Speaker, I concur with the member that this is an issue of concern. I have engaged with the provincial and territorial ministers with regard to this issue. I can say that since 2007, governments and health care providers have developed contingency measures to minimize the impact on patients and that includes using alternate isotopes, such as thallium.
We will continue to work with the experts on medical isotopes to assess the situation and to seek their advice on alternatives. I will continue to work with the provinces and territories.